Category Archives: Wholesale Pharmacy

SANTA BARBARA, Calif., May 21, 2013 /PRNewswire-USNewswire/ --Direct Relief has been reaccredited by the National Association of Boards of Pharmacy (NABP) as a Verified-Accredited Wholesale Distributor (VAWD), through the rigorous national accreditation program developed to help secure the integrity of U.S. drug supply chain, protect public health, and ensure compliance with all national and state licensure requirements, applicable statutes and regulations, and industry-leading practices. The California-based nonprofit organization was the first U.S. nonprofit to obtain VAWD certification in 2009. It remains the only nonprofit licensed to distribute prescription medications in all 50 U.S. states and conducts the country's largest nonprofit charitable medicines program. Three U.S. states require VAWD accreditation as a condition for obtaining a state license to distribute prescription medications. "We were pleased when Direct Relief became the only nonprofit to obtain VAWD accreditation several years ago and we are pleased to have met the heightened standards that now exist," said Direct Relief President and CEO Thomas Tighe. "The accreditation reflects a significant, sustained investment and Direct Relief's commitment to meeting the highest standards of care, legal and regulatory compliance, and best industry practices the standards do not change because they are done by a nonprofit organization on a … Continue reading →

BRAMPTON, ON, May 17, 2013 /CNW/ - TSX:L: Today pharmacists at Real Canadian Superstore, Your Independent Grocer, nofrills, Extra Foods, SuperValu and Wholesale Clublocations are celebrating World Hypertension Day by reminding Canadians to have regular blood pressure checks. In partnership with Hypertension Canada , pharmacists at theselocations recently introduced the Blood Pressure Check Program, an easy, convenient option for consumers to better understand how to manage their blood pressure. The program is exclusive to Loblaw store pharmacies. Please visit http://www.drugstorepharmacy.ca/ to find a location. Customers simply use the in-store machine to take two blood pressure readings and participate in a personal consultation with the pharmacist. During the consultation, the pharmacist reviews the data from the readings along with other health information to provide appropriate, personalized recommendations based on Hypertension Canada's guidelines. "Hypertension Canada is committed to working closely with like-minded partner organizations such as Loblaw store pharmacists and the Blood Pressure Check Program to deliver positive benefits to the 7.4 million Canadians living with high blood pressure on a daily basis." says Judi Farrell , CEO, Hypertension Canada. "It is through these programs that weincrease awareness of high blood pressure and empower Canadians to make healthy lifestyle choices." **What should … Continue reading →

SILVER SPRING, Md., May 15, 2013 /PRNewswire/ --Pharmagen, Inc. (PHRX) (the "Company" or "Pharmagen") today announced financial results for the quarter ended March 31, 2013. On a consolidated basis, revenues for the three months ended March 31, 2013 totaled $1.72 million as compared to the three months ended March 31, 2012, representing a 329% increase year-over-year. Adjusted for nonrecurring expenses, and depreciation and amortization, the company reported a slight profit for the quarter on an EBITDA basis. The company had one-time, non-recurring expenses of approximately $340k, and amortization and depreciation of approximately $335k, representing an operating loss of $666,0000. The companies branded multivitamin Clotamin reported first quarter sales of approximately $500,000, representing a 1,000% increase compared to the first quarter of 2012. Gross margins for the company continue to improve, expanding from 44% in the first quarter of 2012 to 60% in the first quarter of 2013. Margin improvement is being driven primarily from increased sales of Clotamin and revenues generated by Pharmagen Laboratories. Pharmagen Wholesale's license base has expanded to 40 states and Pharmagen Laboratories has expanded to 24 states. The company is weighing a strategic move to North Carolina as it attempts to become an FDA-approved generic manufacture … Continue reading →

By Rupert Steiner PUBLISHED: 16:15 EST, 15 May 2013 | UPDATED: 17:11 EST, 15 May 2013 A host of branded medicines losing their patents caused sales to fall at the firm behind Boots the Chemist, which stocked cheaper generic pills and creams instead. But profits at Alliance Boots, Europes largest pharmacy chain, still managed to grow because it still received the same flat rate per prescription from the Government. The cheaper products meant less cash flowed through its tills, causing sales to fall 2.6 per cent to 22.4billion. Challenging conditions: Chairman Stefano Pessina said: 'We have again delivered a double digit growth in underlying profit after tax.' But unfavourable currency conversions the firm has wholesale operations in 20 countries and a focus on higher margin health and beauty products also played a part. A number of new strategic partnerships including Americas Walgreens taking a 45 per cent stake in Alliance Boots helped boost profit. The tie-up which is likely to result in a formal merger in two years has seen Americas largest pharmacy chain take Boots products. Read the original post: Strategic partnership with US Walgreens helps lift revenue at Boots as pharmacy profits increase £150million … Continue reading →

New Delhi, May 10 (IANS) Around 7.5 lakh chemists across India Friday observed a one-day strike against the new drug policy and its impact on traders. However, in some states, pharmacy shops near major hospitals remained open, providing relief to patients. "We don't want patients to suffer because of our strike," Sandeep Nangia, president of Retailers and Distributors Chemist Association (RDCA), affiliated to the apex All India Organisation of Chemists and Druggists (AIOCD), told IANS. "That is why we have asked chemist shops near all major hospitals to remain open today (Friday), despite the strike," he added. Chemist shop owners near prominent hospitals in Delhi like the All India Institute of Medical Sciences (AIIMS), Safdarjung and Ram Manohar Lohia hospitals, agreed. "The strike is on, but 80 percent of the shops here are open as we cannot let patients suffer," said Rohit Kumar of All India Medicos, near Safdarjung Hospital. A similar response was seen in the eight north-eastern states as some medicine shops remained open, said Tripura Chemists and Druggists Association president Ratan Kumar Roy. "To meet the emergency needs of the patients, some selective medicine shops remained opened in all the eight states of the region," Roy said, … Continue reading →

Mumbai, May 10 (IANS) Over 50,000 retail and wholesale pharmacists and chemists in Maharashtra Friday joined the all-India strike called by the All India Organisation of Chemists and Druggists Associations (AIOCDA) in support of various demands, a top official said. Around 7,500 retail and wholesale pharmacists from Mumbai are also taking part in the nationwide agitation involving around 700,000 retail and wholesale pharmacists, said Pharmaceutical Wholesalers and Retailers Association (PWRA) president Dilip A. Mehta. "We want the margins of the retail chemists to be maintained in the proposed new drug policy, and oppose foreign direct investment in this sector," Mehta told IANS. Besides, the PWRA has demanded that in Maharashtra, the issue of appointing a full-time chemist in all pharmacy shops must be resolved amicably without harassment by the Food and Drugs Administration. "We also demand that we should not be victimised for fake or sub-standard drugs since we do not know what is contained in the packages that are sold. We also strongly oppose Local Body Tax in Maharashtra," Mehta declared. All chemist shops, including those operating round-the-clock, have remained shut from midnight onwards in response to the strike call, inconveniencing hundreds of thousands of customers already suffering due … Continue reading →

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/jg2cpl/the_worldwide) has announced the addition of the "The Worldwide Guide to Pricing & Reimbursement" report to their offering. Provides insight into pharmaceutical pricing and reimbursement systems around the world! The issues of pricing and reimbursement play an important role in determining the likely commercial success of a pharmaceutical product in the marketplace. Following marketing authorisation, the pharmaceutical industry must successfully navigate national regulatory systems to determine the price at which a product can be sold and whether or not it will be eligible for reimbursement by public or private health insurers. So how is pharmaceutical pricing established? There is no simple answer to this question. For other consumer goods, pricing may be as simple as the manufacturer setting a price at which their product can reasonably be sold in a particular market. In other words, a competitive price that is both affordable for the customer and allows the manufacturer to make a profit. For pharmaceutical companies, pricing is often far more complicated. Governments and health insurance providers around the world strive to contain costs while providing effective medicines for their patients. Their efforts to do so have resulted in national pricing policies that include various … Continue reading →

HOUSTON, TX--(Marketwired - May 6, 2013) - (OTCBB: DEWM) (OTCQB: DEWM) Dewmar International BMC, Inc. (www.DewmarInternational.com), an international beverage manufacturer and brand management company specializing in new age functional beverages, has ranked #17 in the 2013 Louisiana State University 100 awards program that honors the fastest growing Tiger businesses. The award is given annually by LSU's Stephenson Entrepreneurship Institute (SEI) to the fastest-growing companies owned by LSU alumni.Dewmar International BMC, Inc. was chosen upon its first year of application of this program which is in its 3rd year of existence. "Our goal continues to be able to provide top quality new age functional products to consumers and offer high profit margins for all of our wholesale and retail partners," said Dr. Marco Moran, president of Dewmar International BMC, Inc. a registered pharmacist who completed his pre-Pharmacy studies at LSU in the early nineties. "Being named to the LSU 100, especially achieving higher rankings than many other well established larger companies, confirms that we are meeting ongoing market needs with offerings that truly make a difference for our shareholders." To be ranked among the 2013 LSU 100, Dewmar International BMC, Inc. competed with other companies internationally based on compounded annual growth … Continue reading →

LONDON--(BUSINESS WIRE)-- Pricing and reimbursement have important roles in evaluation of sales effectiveness of a pharmaceutical product. Failure to comply with pricing levels and reimbursement status can provoke lost profit or restricted therapy choice for both patients and clinicians. In terms of current unfavorable economic conditions pricing controls are used by health payers as a mean to limit drug expenditure. Fixed generic price reductions, reference pricing schemes, companies profits limitations and fixed wholesale and pharmacy mark-ups are some of the common methods utilized by national pricing authorities to arrive at agreed pharmaceutical prices. Another critical factor in price setting is gaining of reimbursement status. Research report The Worldwide Guide to Pricing & Reimbursement designed by Espicom Business Intelligence examines the present state of pricing and reimbursement in 58 leading and emerging economies. It scrutinizes the policies and practices having influence on the pharmaceutical industrys operating environment. The report describes how pricing and reimbursement vary in different regions; each country-wise market analysis includes a comprehensive review of drug pricing, reference pricing, controls, policy, regulation and reimbursement systems as well as influencing factors such as procurement and formulary. Countries covered in the report: Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, the USA, … Continue reading →

CLICKS Group on Thursday warned in its results for the six months ended February that the headwinds of constrained consumer spending and squeezed margins were likely to persist. "I cant see any reason why retail trading conditions are going to change at all in the remainder of this calendar year," CE David Kneale said. "The economy is stuck in a pretty low gear." Like other retailers, the company is faced with consumers who have become more cautious on spending as a result of rising household debt and escalating cost pressures. Clicks reported diluted headline earning per share of 142.7c from 131.5c in the same period last year. Turnover increased 11.4% to R8.5bn, with selling price inflation of 2 % for the period. Equity analyst Daniel Isaacs of 36One Asset Management said that overall, the groups results were disappointing. "They (grew ) diluted earnings 8.5%, which is not great, especially for the price that the stock is trading at. "The results reflect a weak consumer, low inflation and high-cost growth. They mention that pharmacy costs grew 25%, which is quite significant." Turnover growth of 7% in the Clicks chain was driven by increased promotional activity. "In this environment, to move the … Continue reading →